[Proceedings: Anomalies in the regulation of the secretion of corticotropin in chromophobe adenomas].
D000238:Adenoma, Chromophobe / Q000097:blood*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D001120:Arginine; D003397:Craniopharyngioma / Q000097:blood; D007987:Gonadotropin-Releasing Hormone; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007980:Levodopa; D007986:Luteinizing Hormone / Q000378:metabolism; D008797:Metyrapone; D010902:Pituitary Gland / Q000187:drug effects; D010911:Pituitary Neoplasms / Q000097:blood; D013972:Thyrotropin / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone
D007987:Gonadotropin-Releasing Hormone; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D001120:Arginine; D008797:Metyrapone
Anomalies de la régulation de la sécrétion corticotrope dans les adénomes chromophobes